Kan He

827 total citations
20 papers, 662 citations indexed

About

Kan He is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Kan He has authored 20 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Kan He's work include Berberine and alkaloids research (4 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and RNA Interference and Gene Delivery (2 papers). Kan He is often cited by papers focused on Berberine and alkaloids research (4 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and RNA Interference and Gene Delivery (2 papers). Kan He collaborates with scholars based in China, United States and Nepal. Kan He's co-authors include Dan Shao, Xiao Zheng, Li Chen, Yawei Zhao, Lianzhi Cui, Madi Sun, Ying‐Hua Jin, Yinghui Huang, Li Yang and Yong Jia and has published in prestigious journals such as PLoS ONE, Biomaterials and International Journal of Molecular Sciences.

In The Last Decade

Kan He

20 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kan He China 12 319 190 141 112 110 20 662
Meiqun Cao China 13 332 1.0× 268 1.4× 198 1.4× 64 0.6× 84 0.8× 23 900
Shujun Shentu United States 11 417 1.3× 212 1.1× 141 1.0× 121 1.1× 62 0.6× 20 838
Dahua Fan China 8 347 1.1× 256 1.3× 191 1.4× 159 1.4× 44 0.4× 10 764
Hegen Li China 14 256 0.8× 132 0.7× 94 0.7× 109 1.0× 43 0.4× 44 653
Hongzhuan Yin China 19 539 1.7× 144 0.8× 118 0.8× 253 2.3× 46 0.4× 35 915
Jilai Tian China 16 245 0.8× 201 1.1× 155 1.1× 53 0.5× 25 0.2× 32 720
Haibo Cheng China 14 313 1.0× 102 0.5× 43 0.3× 113 1.0× 44 0.4× 31 576
Li-Min Mu China 15 481 1.5× 281 1.5× 360 2.6× 86 0.8× 61 0.6× 24 832
Pradip Chaudhari India 15 311 1.0× 165 0.9× 166 1.2× 50 0.4× 34 0.3× 36 717
Goutam Mondal United States 17 417 1.3× 169 0.9× 230 1.6× 138 1.2× 29 0.3× 28 826

Countries citing papers authored by Kan He

Since Specialization
Citations

This map shows the geographic impact of Kan He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kan He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kan He more than expected).

Fields of papers citing papers by Kan He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kan He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kan He. The network helps show where Kan He may publish in the future.

Co-authorship network of co-authors of Kan He

This figure shows the co-authorship network connecting the top 25 collaborators of Kan He. A scholar is included among the top collaborators of Kan He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kan He. Kan He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Weixin, et al.. (2025). Targeting Metabolism: Innovative Therapies for MASLD Unveiled. International Journal of Molecular Sciences. 26(9). 4077–4077. 2 indexed citations
2.
3.
Shi, Tongfei, Fangman Chen, Xuenian Chen, et al.. (2023). Cationic mesoporous silica nanoparticles alleviate osteoarthritis by targeting multiple inflammatory mediators. Biomaterials. 303. 122366–122366. 29 indexed citations
4.
Ding, Jipeng, et al.. (2023). When type II diabetes mellitus meets COVID‐19—Identification of the shared gene signatures and biological mechanism between the two diseases. European Journal of Clinical Investigation. 53(5). e13955–e13955. 2 indexed citations
5.
Zheng, Xiao, Yawei Zhao, Yong Jia, et al.. (2021). Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis. Biomaterials. 271. 120716–120716. 76 indexed citations
6.
Shi, Tongfei, Yawei Zhao, Jing Li, et al.. (2021). Analysis of Serum Metabolomics in Rats with Osteoarthritis by Mass Spectrometry. Molecules. 26(23). 7181–7181. 10 indexed citations
7.
Cui, Xiaoli, et al.. (2021). New tale on LianHuaQingWen: IL6R/IL6/IL6ST complex is a potential target for COVID-19 treatment. Aging. 13(21). 23913–23935. 9 indexed citations
8.
Zhao, Yawei, Xuehan Yang, Min Zhang, et al.. (2021). Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1. European Journal of Pharmacology. 895. 173887–173887. 19 indexed citations
9.
Zhao, Yawei, Meihui He, Lianzhi Cui, et al.. (2020). Chemotherapy exacerbates ovarian cancer cell migration and cancer stem cell-like characteristics through GLI1. British Journal of Cancer. 122(11). 1638–1648. 28 indexed citations
10.
Zhang, Fan, Yong Jia, Xiao Zheng, et al.. (2019). Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence. Acta Biomaterialia. 100. 352–364. 54 indexed citations
11.
Shi, Tongfei, Meihui He, Yawei Zhao, et al.. (2019). 5-FU preferably induces apoptosis in BRAF V600E colorectal cancer cells via downregulation of Bcl-xL. Molecular and Cellular Biochemistry. 461(1-2). 151–158. 6 indexed citations
12.
Zhao, Yawei, Yong Jia, Tongfei Shi, et al.. (2019). Depression promotes hepatocellular carcinoma progression through a glucocorticoid-mediated upregulation of PD-1 expression in tumor-infiltrating NK cells. Carcinogenesis. 40(9). 1132–1141. 28 indexed citations
13.
Zhang, Fan, Ming Zhang, Xiao Zheng, et al.. (2018). Berberine-based carbon dots for selective and safe cancer theranostics. RSC Advances. 8(3). 1168–1173. 33 indexed citations
14.
Zhang, Fan, Yawei Zhao, Kan He, et al.. (2018). Obesity-associated miR-27a upregulation promotes hepatocellular carcinoma metastasis through suppressing SFRP1. OncoTargets and Therapy. Volume 11. 3281–3292. 10 indexed citations
15.
Zheng, Xiao, Fan Zhang, Yawei Zhao, et al.. (2018). Self-assembled dual fluorescence nanoparticles for CD44-targeted delivery of anti-miR-27a in liver cancer theranostics. Theranostics. 8(14). 3808–3823. 47 indexed citations
16.
Cui, Lianzhi, Yawei Zhao, Yue Pan, et al.. (2017). Chemotherapy induces ovarian cancer cell repopulation through the caspase 3-mediated arachidonic acid metabolic pathway. OncoTargets and Therapy. Volume 10. 5817–5826. 24 indexed citations
17.
Wang, Zheng, Zhimin Chang, Mengmeng Lu, et al.. (2017). Shape-controlled magnetic mesoporous silica nanoparticles for magnetically-mediated suicide gene therapy of hepatocellular carcinoma. Biomaterials. 154. 147–157. 132 indexed citations
18.
19.
Zhuo, Zhan, Kan He, Dan Jiang, et al.. (2012). Phosphorylation of Rad9 at Serine 328 by Cyclin A-Cdk2 Triggers Apoptosis via Interfering Bcl-xL. PLoS ONE. 7(9). e44923–e44923. 10 indexed citations
20.
Yang, Li, Kan He, Yinghui Huang, et al.. (2010). Betulin induces mitochondrial cytochrome c release associated apoptosis in human cancer cells. Molecular Carcinogenesis. 49(7). 630–640. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meiqun Cao Breakdown of academic impact, for papers by Shujun Shentu Breakdown of academic impact, for papers by Dahua Fan Breakdown of academic impact, for papers by Hegen Li Breakdown of academic impact, for papers by Hongzhuan Yin Breakdown of academic impact, for papers by Jilai Tian Breakdown of academic impact, for papers by Haibo Cheng Breakdown of academic impact, for papers by Li-Min Mu Breakdown of academic impact, for papers by Pradip Chaudhari Breakdown of academic impact, for papers by Goutam Mondal
Rankless by CCL
2026